Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 6-7 , January 2003

Angina Pain Precipitated by a Continuous Subcutaneous Infusion of Ketamine

  • Jason Ward, MB BS, MRCGP

      Affiliations

    • St. James's University Hospital Leeds, United Kingdom
    • ,
  • Claire Standage, MRPharmS, ClinDip

      Affiliations

    • St. Gemma's Hospice Leeds, United Kingdom

References 

  1. Luczak J, Dickinson AH, Kotlinska-Lemieszek A. The role of ketamine, an NMDA receptor antagonist, in the management of pain. Prog Palliat Care. 1995;3:127–134
  2. Finlay I. Ketamine and its role in cancer pain. Pain Reviews. 1999;6:303–313
  3. Mercadante S. Ketamine in cancer pain (an update). Palliat Med. 1996;10:225–230
  4. Twycross R. Symptom management in advanced cancer. 2nd ed. Oxford: Radcliffe Medical Press; 1997; :12
  5. Jackson K, Ashby M, Martin P, et al.  Burst ketamine for refractory cancer pain (an open-label audit of 39 patients). J Pain Symptom Manage. 2001;22:834–842
  6. Reynolds JEF. Martindale (the extra pharmacopoeia). London: Royal Pharmaceutical Society; 1996; :1258
  7. Vickers MD, Morgan M, Spencer PSJ, et al.  In: Drugs used in anaesthetic and intensive care practice. 8th ed. Oxford: Butterworth Heinemann; 1999;p. 104–107

PII: S0885-3924(02)00603-6

Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 6-7 , January 2003

Article Tools